³ÉÈËVRÊÓƵ

Un congrès international sur les dernières avancées dans le traitement de l'infertilité, la contraception, la ménopause et les dysfonctions sexuelles se tiendra à Montréal, du 2Ìýau 4Ìýjuin, à l'Hôtel Reine-Élizabeth. Il est organisé par les départements d'obstétrique et de gynécologie de l'Université ³ÉÈËVRÊÓƵ et de l'Université de Montréal. Le Congrès est placé sous la présidence du DrÌýSeang LinÌýTan, directeur du département d'obstétrique et de gynécologie de l'Université ³ÉÈËVRÊÓƵ et chef de l'obstétrique et de la gynécologie au Centre universitaire de santé ³ÉÈËVRÊÓƵ (CUSM).

« ÌýCe congrès mondial est un événement marquant dans le domaine et il se tient pour la première fois au Canada. Nous avons réuni une brochette prestigieuse de médecins et de chercheurs de renom qui exposeront les plus récentes recherches en santé de la reproductionÌý», dit le DrÌýTan.

Le programme du congrès comprend des conférences de médecins et de chercheurs de réputation internationale venus du monde entier, notamment de l'Australie, du Canada, des États-Unis, de la France, d'Israël et du Royaume-Uni. Au nombre des sujets d'intérêtÌý:

• Le clonage reproductif
• La recherche sur les cellules souches embryonnaires humaines
• La production du bébé sur mesure
• Le déclin de la fertilitéÌý: mythe ou réalité?
• La contraception chez les femmes de plus de 40Ìýans
• La maturation inÌývitro des ovocytes pour le traitement de l'infertilité

Les journalistes qui souhaitent réaliser des entrevues sont priés de contacter le service des Communications du CUSM antérieurement au Congrès. On notera que les caméras et les micros ne seront pas autorisés dans les salles de séminaires. Pour obtenir davantage de renseignements, consulter le programme du Congrès.

Le Congrès se tiendra en anglais.

Pour obtenir d'autres renseignements, veuillez contacterÌý:

ChristineÌýZeindler, M.Sc.
Coordonnatrice des communications (Recherche)
Service des Communications du Centre universitaire de santé ³ÉÈËVRÊÓƵ
(514) 934-1934, posteÌý36419
TéléavertisseurÌý: (514) 406-1577

Ìý

11^th World Congress on Human Reproduction Agenda

Sunday, June 2

8:30 am — 10:15 am Plenary Session

Reproductive and Therapeutic Cloning

1. Reproductive cloning of animals — where are we today? — Paul De Sousa (UK)
2. Cloning of human beings — how feasible is it today? — Jacques Cohen (USA)
3. Stem cell research and human reproduction —Anne McLaren (UK)

10:15 am — 11:00 am Coffee Break

11:00am — 12:30 pm Concurrent Sessions

LHRH antagonists and recombinant gonadotropins.

1. The use of recombinant gonadotropins in assisted reproduction - Ernest Loumaye (USA)
2. Indications for use of LHRH antagonists in infertility treatment today — Ricardo Felberbaum (Germany)
3. Single dose versus multiple dose therapy — Ricardo Felberbaum (Germany)
4. Effects on implantation — Sergio Oehninger (USA).

Hormone replacement therapy

1. Monitoring of patients on long term HRT — Malcolm Whitehead (UK)
2. Role of soy products and other natural products for HRT - Jennifer Blake (Canada)
3. Choice between micronized progesterone and MPA — Elaine Jolly (Canada)
4. Indications and timing of starting HRT in pre-menopausal women — Morrie Gelfand (Canada)

Hysteroscopy and endometrial ablation

1. Hysteroscopy 2002 — Jacques Hamou (France)
2. Photodynamic endometrial ablation — Robert Reid (Canada)
3. Office hysteroscopy and endometrial ablation — Barry Sanders (Canada)
4. Microhysteroscopy — Peter O'Donovan (UK)

Abnormal uterine bleeding

1. Modern work-up for abnormal uterine bleeding — Kees Wamsteker (Netherlands)
2. Diagnosis of adenomyosis by ultrasound and MRI — Caroline Reinhold (Canada)
3. Pathological basis of abnormal uterine bleeding — Alex Ferenczy (Canada)
4. Importance of fluid monitoring — Franklin Loffer (USA)

12:30 pm — 2:00 pm Lunch Break

2:00 pm — 3:30 pm Concurrent Sessions

Hormone replacement therapy

1. Risks and benefits of HRT — Robert Reid (Canada)
2. Risk of breast cancer with long term HRT — Richard Margolese (Canada)
3. Place of life long HRT with availability of SERMS — Leo Plouffe (Canada)
4. Hormonal strategy in the management of menopausal women - Marian Damewood (USA)

Update in ART

1. Feasibility of single embryo transfer in IVF — Lars Hamberger (Sweden)
2. Embryo assessment to optimize pregnancy rates - Jacques Cohen (USA)
3. Cryopreservation of human oocytes — David Winniger (USA)
4. Effects of league tables and strict policies on the number of embryos transferred on the practice of IVF — Hossam Abdallah (Egypt)

Induction of ovulation

1. Neuroendocrinology of reproduction — Robert Rebar (USA)
2. How do I choose the ideal gonadotropins for my patients? — Roy Homburg (Israel)
3. Fertility drugs and breast and ovarian cancer — what is the evidence? — Bruno Lunenfeld (Israel)
4. Risks of ovarian stimulation and pregnancy after history of breast cancer — Richard Margolese (Canada)

Laparoscopy & hysteroscopy— recent developments

1. Place of laparoscopic tubal anastomosis — Tae-Ki Yoon (Korea)
2. Transvaginal hydrolaparoscopy — Stephen Gordts (Belgium)
3. Effects of CO₂ gas on peritoneum — Douglas Ott (USA)
4. Hysteroscopic vs non-hysteroscopic endometrial ablation — Milton Goldrath (USA).

3:30 pm — 4:00 pm Coffee Break

4:00 pm — 5:30 pm Concurrent Sessions

Aging male and female

1. The andropause — fact or fiction — Bruno Lunenfeld (Israel)
2. Sexual dysfunction in aging men — Serge Carrier (Canada)
3. Risks of growth hormone and testosterone for the aging male — Howard Jacobs (UK)
4. Menopause and heart disease — Wulf Utian (USA)

PCOS and infertility

1. Significance of ultrasound diagnosis of polycystic ovaries without clinical or endocrinological features — Howard Jacobs (UK)
2. Rational use of metformin in PCOS associated with infertility — Gabor Kovacs (Australia)
3. Surgical treatment of PCOS — Adam Balen (UK)
4. Non-fertility risks of PCOS — David Morris (Canada)

Endometriosis & ART

1. Optimum surgical treatment for endometriomas — Liselotte Mettler (Germany)
2. Common genetic changes between endometriosis and ovarian cancer — Hiroshi Hoshiai (Japan)
3. Ovarian suppression — Andrea Genazzani (Italy)
4. Optimising embryo transfer — an evidence-based approach — Hassan Sallam (Egypt)

Uterine diseases

1. Uterine anomalies and infertility — John Rock (USA)
2. Diagnosis of non-gynecological causes of pelvic pain - Albert Cohen (Canada)
3. Myoma, infertility and IVF — Shlomo Mashiach (Israel.)
4 Optimal treatment of uterine synechiae — Robert Neuwirth (USA).

---

Monday, June 3

7:00 am — 8:30 am Plenary Session - Sponsored by NovoNordisk

Advances in in-vitro maturation of oocytes

1. The role of FF-MAS in in-vitro maturation of oocytes — Christian Grondhal (Denmark)
2. The impact of different culture environments on the in-vitro maturation potential and genetics of human oocytes — Helen Picton (UK)
3. Is IVM feasible for non-selected, non-PCO patients? — Peter Plateau (Belgium)

8:30 am — 10:15 am Plenary Session

The future of reproductive technologies
1. In-vitro maturation of human oocytes for the treatment of infertility — Seang Lin Tan (Canada)
2. The human genome project: Relevance to human disease - Tom Hudson (Canada)
3. The designer baby — Robert G. Edwards (UK)

10:15 am — 11:00 am Coffee Break

11:00am — 12:30 pm Concurrent Sessions

Management of infertility: "From laboratory to clinical outcomes"

A Serono Educational Event (SEE)

1. Assessing embryo quality: "A significant difference between two r-FSH preparations". — Catherine Racowsky (USA)
2. German Phase III open multi-center study to evaluate the convenience and safety of recombinant FSH injections supplied as 1200 IU multi-dose (Gonal-F Multi Dose^â) in ART cycles — Miguel J. Hinrichsen (Germany)
3. Optimizing outcomes in the treatment of infertility —Ernest Loumaye (Switzerland)

Advances in Male factor infertility treatment

1. Testicular and epididymal sperm for ICSI — Zev Rosenwaks (USA)
2. Medical treatments of erectile dysfunction — Yosh Taguchi (Canada)
3. Are old sperms still good? — Bernard Robaire (Canada)
4. Spermatozoon as a vehicle for HIV-I and other viruses — Richard Lalonde (Canada)

Endometriosis

1. New concepts in management — Liselotte Mettler (Germany)
2. HRT after BSO — David Redwine (USA)
3. Should endometriomas be removed before IVF? — Rene Frydman (France)
4. Is burning or excision preferable for endometriotic surgery — David Redwine (USA)

Laparoscopic surgery

1. Place of laparoscopic supra-cervical hysterectomy — Michelle Nisolle (Belgium)
2. Role of laparoscopic vs laparotomy for hysterectomy — Christopher Sutton (UK)
3. Removal of ovaries at hysterectomy in pre-menopausal women — Malcolm Whitehead (UK)
4. Laparoscopic radical hysterectomy — Farr Nezhat (USA)

12:30 pm — 2:00 pm Lunch Break

2:00 pm — 3:30 pm Concurrent Sessions

Assisted Reproductive Technology

1. Micro anatomy of human IVF and early embryo genesis — Pietro Motta (Italy)
2. Blastocyst culture — does it improve pregnancy rates? — Amin Milki (USA)
3. Recombinant FSH and LH — Zeev Shoham (Israel)
4. Nuclear and cytoplasmic transfer — Jacques Cohen (USA)

SERMS

1. Advances in SERM therapy — Wulf Utian (USA)
2. Comparison between Fosamax and Raloxifen - Malcolm Whitehead (UK)
3. Endometrial effects of SERMS — Leo Plouffe (USA)
4 Prevention of osteoporosis — role of SERMS — David Goltzman (Canada)

Ectopic pregnancy and pelvic pain

1. Patient assisted laparoscopy — Larry Demco (Canada)
2. Pain mapping by laparoscopy and miniendoscopy — Larry Demco (Canada)
3. Salpingostomy vs salpingectomy — Victor Gomel (Canada)
4. Non-laparoscopic evaluation of pelvic pain - Deborah Metzger (USA)

Ethics and reproduction

1. Dogmatic ethicism — Albert Yupze (Canada)
2. Ethical implications of genetic screening — Françoise Shenfield (UK)
3. Comparative regulatory systems governing ART — Joseph Schenker (Israel)
4. Stem cell research — ethical considerations - Margaret Somerville (Canada)

3:30 pm — 4:00 pm Coffee Break

4:00 pm — 5:30 pm Concurrent Sessions

Ultrasound and infertility

1. Place of ultrasound guided embryo transfer — Sergio Oehninger (USA)
2. Requirements for certification of ultrasound — Lucie Morin (Canada)
3. Management of hydrosalpinges in women undergoing IVF — Mohamed Aboulghar (Egypt)

Implantation

1. The implantation window — Bruce Lessey (USA)
2. Impact of oocyte quality — Hugh Clarke (Canada)
3. Endometrial factors and implantation — Yuji Taketani (Japan)

Menopause

1. Androgen therapy — Morrie Gelfand (Canada)
2. Sex hormones and brain function — Barbara Sherwin (Canada)
3. Osteoporosis — Alan Tennenhouse (Canada).

Ovarian stimulation with urinary gonadotropins

1. Use of urinary gonadotropins by subcutaneous injection — Albert Yuzpe (Canada)
2. Control of follicular recruitment — Klaus Diedrich (Germany)
3. Role of Coasting - Jehoshua Dor (Israel)

---

Tuesday, June 4

8:30 am — 10:15 am Plenary Session

Highlights of reproductive science

1. Decline of fertility in the human race- what is the evidence? - John Aitken (Australia)
2. Cryopreservation and transplantation of human ovarian tissue — Roger Gosden (Canada)
3. Genetics of infertility — David Page (USA)

10:15 am — 11:00 am Coffee Break

11:00am — 12:30 pm Concurrent Sessions

Management of common reproductive disorders

1. Hirsutism — Vivian Lewis (USA)
2. Amenorrhea — Zephne Van der Spuy (South Africa)
3. Pre-menstrual syndrome — Robert Reid (Canada)
4. Hyperprolactinemia — Yogesh Patel (Canada)

Recurrent pregnancy loss

1. Evidence for immunotherapy and recurrent pregnancy loss — Salim Daya (Canada)
2. Thrombophilia and recurrent pregnancy loss — Susan Kahn (Canada)
3. Pre-implantation genetic diagnosis as final treatment for recurrent miscarriage — Asangla Ao (Canada)
4. The role of Mitochondria and Aging Ovary - Chii-Ruey Tzeng (Taiwan)

Management of the infertile couple

1. Infertility work-up 2002 — Charles Coddington (USA).
2. Management of ovarian hyperstimulation syndrome — Mohamed Aboulghar (Egypt)
3. Subtle factors in unexplained infertility — Michael Diamond (USA)
4. Pre-conception care — Alice Benjamin (Canada)

Allied Health and Patient Issues

1. Academic fertility centers — strategies for cost-effective management — Anna-Maria Henderson (Canada)
2. Role of support organizations — Norman Barwin (Canada)
3. Counseling sperm and egg donors — Janet Takefman (Canada)
4. Strategies for developing a strong support group — Lone Hummelshoj (UK)

12:30 pm — 2:00 pm Lunch Break

2:00 pm — 3:30 pm Concurrent Sessions

Contraception — Sponsored by Berlex Canada

1. Ultra low dose contraception — Timothy Rowe (Canada)
2. Emergency contraception — Albert Yuzpe (Canada)
3. Third generation oral contraceptives — safety and indications for use — Walter Spitzer (USA)
4. Treatment of acne — Serge Belisle (Canada)

Genetics, aging and fertility

1. Mitochondria and oocyte aging — Eric Shoubridge (Canada)
2. The genetics of infertility — what about PCOS? — Jennifer Wood (USA)
3. Genomic imprinting and fetal loss — Jacquetta Trasler (Canada)
4. Oocyte and sperm aging and its effects on fertility - Alan Handyside (UK)

Adhesions

1. Prevention by adhesions — Michael Diamond (USA)
2. Peritoneal repair — Arthur Haney (USA)
3. Animal model — David Wiseman (USA)
4. Growth factors — Nasser Chegini (USA)

Sexually transmitted disease and reproduction

1. Ethical issues involved in the treatment of HIV positive couples — Benjamin Younger (USA)
2. Why are women's groups not more active in the fight against AIDS — Mark Wainberg (Canada)
3. Abnormal cytology among HIV infected women — Alex Ferenczy (Canada)
4. Influence of HIV infection on PID — Chris Tsoukas (Canada)

3:30 pm — 4:00 pm Coffee Break

4:00 pm — 5:30 pm Concurrent Sessions

Uterine artery embolization

1. Uterine artery embolization in young women — is there a role? — Togas Tulandi (Canada)
2. Management of uterine fibroid: an overview — Charles Coddington (USA)
3. Indications and success rates for uterine artery embolization for fibroids — Francis Hutchins (USA)
4. Complications of uterine artery embolization — Lawrence Stein (Canada)

Contraception in women over 40 years

1. Choice of medical contraception in women over 40 years — Jennifer Blake (Canada)
2. Risks: perception vs reality — Timothy Rowe (Canada)
3. Management of practical problems — Elaine Jolly (Canada)
4. OC until HRT — benefits and risks — Victoria Davis (Canada)

Meta-analyses and reproductive science

1. Meta-analysis vs large prospective randomized trial — David Guzick (USA)
2. Meta-analysis — strengths and weaknesses — Walter Spitzer (USA)
3. Evidenced based ART treatment by meta-analysis — John Collins (Canada).
4. Evidenced based infertility treatment by meta-analysis — Salim Daya (Canada)

Reproductive Health and Alternative Medicine

1. Obesity and reproduction — Zephne Van der Spuy (South Africa)
2. Complementary and alternative medicine — Machelle Seibel (USA)
3. Infertility and energy healing — Robert McInnes (USA)
4. Acupuncture and reproduction — Joseph Wong (Canada)